Literature DB >> 7184889

Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979.

Y Katsube, J W Berg, S G Silverberg.   

Abstract

We report a population-based histopathologic review of primary ovarian neoplasms. No significant changes in incidence were encountered between the 1969 and 1979 review periods. The most frequent single tumor was benign cystic teratoma (26.5%), while the coelomic-derived "epithelial" tumors constituted the most frequent group (57.6% of all tumors and 93.8% of all malignant tumors). The high frequency of borderline tumors reported by others in nonpopulation-based material is confirmed, and the usual disseminated state of invasive carcinomas at the time of diagnosis is noted. Other data concerning incidence and bilaterality rates, patient ages, multiple primary malignancies, and problems in differential diagnosis and tumor grading are discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7184889     DOI: 10.1097/00004347-198201000-00003

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  14 in total

Review 1.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

2.  Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.

Authors:  Khashayar Esfahani; Cristiano Ferrario; Philippe Le; Lawrence Panasci
Journal:  BMJ Case Rep       Date:  2014-06-12

3.  Borderline ovarian tumor in pregnancy: can surgery wait? A case series.

Authors:  Ailyn M Vidal Urbinati; Anna D Iacobone; Raffaela C Di Pace; Ida Pino; Maria R Pittelli; Maria E Guerrieri; Eleonora P Preti; Dorella Franchi
Journal:  Arch Gynecol Obstet       Date:  2021-05-05       Impact factor: 2.344

4.  Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.

Authors:  Charles W Drescher; Sarah Hawley; Jason D Thorpe; Simone Marticke; Martin McIntosh; Sanjiv S Gambhir; Nicole Urban
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-02

5.  Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

Authors:  Ipsita Mohapatra; Subha R Samantaray; Nikku Harshini
Journal:  Cureus       Date:  2022-04-13

6.  The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors.

Authors:  Hyo Young Jeoung; Han Song Choi; Yo Sup Lim; Min Young Lee; Soo A Kim; Sei Jun Han; Tae Gyu Ahn; Sang Joon Choi
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

7.  Ovarian squamous cell carcinoma arising from mature cystic teratoma.

Authors:  Kavitha Parithivel; Jyothi Priya Jagannathan; Katherine Krajewski; Kevin O'Regan; Charles Matthew Quick; Nikhil Ramaiya; Susana Campos
Journal:  Cancer Imaging       Date:  2011-06-15       Impact factor: 3.909

8.  Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms.

Authors:  S Munakata; T Enomoto; M Tsujimoto; Y Otsuki; H Miwa; H Kanno; K Aozasa
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  Parameters of blood count and tumor markers in patients with borderline ovarian tumors: a retrospective analysis and relation to staging.

Authors:  Rosekeila Simões Nomelini; Taísa Morete da Silva; Beatriz Martins Tavares Murta; Eddie Fernando Candido Murta
Journal:  ISRN Oncol       Date:  2012-04-17

10.  A synchronous presentation of two different ovarian tumors: a rare occurrence.

Authors:  D Sethi; C Ahluvalia; U Sharma; S Khetarpal
Journal:  Ann Med Health Sci Res       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.